At enrolment in active surveillance |
Multiparametric MRI if not previously performed |
Year 1 of active surveillance |
Every 3–4 months: measure PSA |
Throughout active surveillance: monitor PSA kinetics |
Every 6–12 months: DRE |
At 12 months prostate rebiopsy |
Years 2–4 of active surveillance |
Every 3–6 months: measure PSA |
Throughout active surveillance: monitor PSA kinetics |
Every 6–12 months: DRE |
Year 5 and every year thereafter until active surveillance ends |
Every 6 months: measure PSA |
Throughout active surveillance: monitor PSA kinetics |
Every 12 months: DRE |